Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Page 1
Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy.
Benelli E, Trombetta A, Badina L, Andrade S, Zamagni G, Prisco A, Traini E, Barbi E, Berti I. Benelli E, et al. Among authors: berti i. Immun Inflamm Dis. 2022 Jul;10(7):e668. doi: 10.1002/iid3.668. Immun Inflamm Dis. 2022. PMID: 35759227 Free PMC article.
CONCLUSIONS: In this cohort of children with persistent CMA undergoing OIT who presented with respiratory reactions with wheezing, the development of anaphylaxis with the need for IM adrenaline, and age above 10 years were predictors of poor long-term outcome....
CONCLUSIONS: In this cohort of children with persistent CMA undergoing OIT who presented with respiratory reactions with wheezing, the devel …
Life-threatening anaphylaxis in children with cow's milk allergy during oral immunotherapy and after treatment failure.
Badina L, Burlo F, Belluzzi B, Babich S, Berti I, Barbi E. Badina L, et al. Among authors: berti i. Immun Inflamm Dis. 2022 Apr;10(4):e607. doi: 10.1002/iid3.607. Immun Inflamm Dis. 2022. PMID: 35349753 Free PMC article.
METHODS: This is a retrospective cohort study among children with persistent CMA undergoing OIT over a 20-year period, following a specific Oral Tolerance Induction protocol. Adverse reactions during the whole period and data on long-term outcome were registered. Descripti …
METHODS: This is a retrospective cohort study among children with persistent CMA undergoing OIT over a 20-year period, following a specific …
Early introduction oral immunotherapy for IgE-mediated cow's milk allergy: A follow-up study confirms this approach as safe and appealing to parents.
Badina L, Levantino L, Carrato V, Peruch G, Celsi F, Barbi E, Berti I, Longo G. Badina L, et al. Among authors: berti i. Immun Inflamm Dis. 2021 Sep;9(3):918-922. doi: 10.1002/iid3.447. Epub 2021 May 18. Immun Inflamm Dis. 2021. PMID: 34002933 Free PMC article.
In real life, this approach can be complicated, time-consuming, and anxiety-provoking for parents. We assessed the long-term safety of E-OIT for CMA in a cohort of children who switched to an unrestricted diet without testing the achievement of tolerance at the end of the …
In real life, this approach can be complicated, time-consuming, and anxiety-provoking for parents. We assessed the long-term safety o …
IgE-mediated food allergy in children.
Longo G, Berti I, Burks AW, Krauss B, Barbi E. Longo G, et al. Among authors: berti i. Lancet. 2013 Nov 16;382(9905):1656-64. doi: 10.1016/S0140-6736(13)60309-8. Epub 2013 Jul 9. Lancet. 2013. PMID: 23845860 Review.
Prognosis is good for the most frequent allergens with almost all children outgrowing their allergy. However, the long-term implications for disease burden are substantial for children with persistent allergies (eg, peanuts, tree nuts, fish, and shellfish) and for those wi …
Prognosis is good for the most frequent allergens with almost all children outgrowing their allergy. However, the long-term implicati …
Mass screening for coeliac disease using antihuman transglutaminase antibody assay.
Tommasini A, Not T, Kiren V, Baldas V, Santon D, Trevisiol C, Berti I, Neri E, Gerarduzzi T, Bruno I, Lenhardt A, Zamuner E, Spanò A, Crovella S, Martellossi S, Torre G, Sblattero D, Marzari R, Bradbury A, Tamburlini G, Ventura A. Tommasini A, et al. Among authors: berti i. Arch Dis Child. 2004 Jun;89(6):512-5. doi: 10.1136/adc.2003.029603. Arch Dis Child. 2004. PMID: 15155392 Free PMC article.
AIMS: To determine coeliac disease prevalence by an anti-transglutaminase antibody assay in a large paediatric population; to evaluate acceptance of the screening programme, dietary compliance, and long term health effects. METHODS: Cross-sectional survey of 3188 schoolchi …
AIMS: To determine coeliac disease prevalence by an anti-transglutaminase antibody assay in a large paediatric population; to evaluate accep …
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease.
Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, Fasano A, Ventura A, Not T. Sblattero D, et al. Among authors: berti i. Am J Gastroenterol. 2000 May;95(5):1253-7. doi: 10.1111/j.1572-0241.2000.02018.x. Am J Gastroenterol. 2000. PMID: 10811336
Furthermore, early identification and treatment of patients with celiac disease in an outpatient setting could have significant implications for reducing long-term morbidity and can produce major savings in future health care costs....
Furthermore, early identification and treatment of patients with celiac disease in an outpatient setting could have significant implications …